Search Results
, 96 (3), 200–209. 6 Ruttmann, E., Bonatti, H., Legit, C., et al.: Severe endocarditis in transplant recipients – an epidemiologic study. Transpl. Int., 2005, 18
Az anti-SARS-CoV-2-IgG-antitest-immunválaszok monitorozása magyarországi egészségügyi dolgozók két kohorszában fertőzést, illetve immunizálást követően
Monitoring of anti-SARS-CoV-2 IgG antibody immune responses in two cohorts of Hungarian healthcare workers following infection or immunization
162b2 vaccine recipients. Lancet 2021; 397: 875–877. 11 Chemaitelly H, Tang P, Hasan MR, et al. Waning of BNT162b2 vaccine protection against SARS
Subcutan és intramuscularis heterotop kalcifikáció a nyakon 42 évvel a sugárkezelést követően
Subcutaneous and intramuscular heterotopic calcification of the neck 42 years after radiotherapy
–376. 27 Kim JM, Kim SA, Kwon HJ, et al. Reconstruction of radiation-induced ulcers with free flaps using the perforating vessel as a recipient vessel. Microsurgery 2019; 39: 613
Primer szklerotizáló cholangitisben szenvedő, májtranszplantációra váró beteg sikeres várandóssága
Successful pregnancy of a patient with primary sclerosing cholangitis awaiting liver transplantation
–694. 10 Zalewska K. NHS-POL195/6 – Liver transplantation: selection criteria and recipient registration. 02/05/17. Available from: http://odt.nhs.uk/pdf/liver_selection_policy.pdf [accessed
Infekciók kockázatának csökkentése veleszületett és szerzett komplementdefektusokban.
Irodalmi áttekintés és javaslat hazai gyakorlatra
Reducing the risk of infections in hereditary and acquired complement deficiencies.
Review of the literature and proposal for best practice in Hungary
://www.cdc.gov/meningococcal/clinical/eculizumab.html [accessed: February 2, 2023]. 22 Crew PE, McNamara L, Waldron PE, et al. Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease. J
Az allogén vérképző őssejtátültetés korai szövődményei gyermekkorban
Early complications aft er allogeneic stem cell transplantation in childhood
. 2020; 10.1111. published online. 14 Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL
Sheean P, Braunschweig C: The incidence and impact of dextrose dose on hyperglycemia from parenteral nutrition (PN) exposure in hematopoietic stem cell transplant (HSCT) recipients. JPEN J Parenter Enteral Nutr 30, 345–350 (2006
G. Hirschfield 2001 Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are inter-related risk factors for chronic
are most commonly associated with opportunistic localized or disseminated infections in immunocompromised hosts, particularly those with impaired cell-mediated immunity, such as transplant recipients, patients with solid organ or hematological
Listeriosis myeloma multiplexben
Listeriosis in myeloma multiplex
. J Infect Chemother 2010 ; 16 ( 2 ): 123 – 125 . https://pubmed.ncbi.nlm.nih.gov/20112040/ . [13] Wiesmayr S , Tabarelli W , Stelzmueller I , et al. Listeria meningitis in transplant recipients . Wien Klin Wochenschr . 2005; Mar